TSC Ratings' Updates: Bristol-Myers

Revenue rose by 11.3% since the same quarter a year ago, outpacing the industry average of 9.8% and boosting EPS, which are up 7.4% in the most recent quarter compared with the same quarter last year. During the past fiscal year, SAIC increased its bottom line by earning 94 cents vs. 40 cents in the prior year, and this year, the market expects further improvement to $1.09. Net income growth of 14.3% compared with the same quarter a year ago significantly exceeded that of the S&P 500 and the IT services industry. ROE has improved slightly, which can be construed as a modest strength in the organization.

Other ratings changes include Kirby Group(KEX Quote), downgraded from buy to hold, and Presitge Brands Holdings(PBH Quote), upgraded from hold to buy.

All ratings changes generated on Dec. 23 are listed below.

Ticker Company Current Change Previous BEST Shiner International SELL Initiated BMY Bristol-Myers Squibb BUY Upgrade HOLD DUCK Duckwall-Alco Stores SELL Downgrade HOLD JEF Jefferies Group SELL Downgrade HOLD KEX Kirby Group HOLD Downgrade BUY KGC Kinross Gold BUY Upgrade HOLD MHS Medco Health Solutions BUY Upgrade HOLD MMS Maximus HOLD Downgrade BUY NTLS Ntelos Holdnigs BUY Upgrade HOLD OPNT Opnet Technologies HOLD Downgrade BUY PBH Prestige Brands Holdings BUY Upgrade HOLD PBT Permian Basin Royalty Trust HOLD Downgrade BUY PMC Pharmerica SELL Downgrade HOLD RZ Raser Technologies SELL Initiated SAI SAIC BUY Upgrade HOLD SJW SJW BUY Upgrade HOLD TACT Transact Technologies SELL Downgrade HOLD VSNT Versant HOLD Downgrade BUY WX WuXi PharmaTech SELL Initiated SWHC Smith & Wesson Holding SELL Downgrade

Each business day, TheStreet.com Ratings updates its ratings on the stocks it covers. The proprietary ratings model projects a stock's total return potential over a 12-month period, including both price appreciation and dividends. Buy, hold or sell ratings designate how the Ratings group expects these stocks to perform against a general benchmark of the equities market and interest rates.

While the ratings model is quantitative, it uses both subjective and objective elements. For instance, subjective elements include expected equities market returns, future interest rates, implied industry outlook and company earnings forecasts. Objective elements include volatility of past operating revenue, financial strength and company cash flows.

However, the rating does not incorporate all of the factors that can alter a stock's performance. For example, it doesn't always factor in recent corporate or industry events that could affect the stock price, nor does it include recent technology developments and competitive dynamics that may affect the company.

For those reasons, we believe a rating alone cannot tell the whole story, and that it should be part of an investor's overall research.